Get Our Free Research Email
Conference Calendar 
May 20-23 - Current Concepts in Joint Replacement Spring 2012
May 23-25 - 13th EFORT Congress 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
April 2007
Earnings Large Joints Zimmer reported income of $233.4 million, or $0.98 per share, beating estimates of $0.93. The quarter compares to a profit of $205.6 million, or $0.82 per share in 1Q:06. Revenue rose 10% to $950.2 million from $860.4... more
The FDA recommended the approval of Link's Scandinavian Total Ankle Replacement System (S.T.A.R.) after a favorable advisory panel vote of 4-2. If approved, the device would be the first mobile bearing ankle marketed in the U.S. Although mobile bearing ankles... more
Stryker's 1Q:07 earnings call last week highlighted strong profits, but Chief Executive Stephen MacMillan noted a potential snag in its pipeline - OP-1 putty, the company's bone morphogenic protein for spinal fusion indications, may not reach the market until late... more
Last week, we attended the Society for Biomaterials' annual conference. The event showcases the latest academic research and its broad applications across medical specialties. Roughly a third of the poster presentations focused on orthopedics, and most of the rest related... more
Earnings Stryker announced 1Q:07 earnings on Wednesday. Net income increased to $243.5 million, or $0.59 per share, beating analysts' estimates of $0.58 per share. In the comparable quarter, net income was $147.5 million, or $0.36 per share. Revenues increased 13%... more
Vancouver, Canada, April 19, 2007 /PRNewswire/--MicroDTI announced the appointment of Edward Shellard as its Chief Executive Officer. Dr. Shellard is a well-respected dental industry executive and was most recently the President of Kerr. Ed had his own private practice in... more
Hailing hip replacement as one of the "great success stories of modern medicine," the New York Times published an article on Saturday emphasing the benefits of hip resurfacing as an interim step before traditional total hip replacement. There are a... more
The Medical Device User Fee and Modernization Act (MDUFMA II) will expire this September, and yesterday the FDA submitted their proposed recommendations for the Act's reauthorization. MDUFMA is medical device user fee program, wherein industry pays fees to support the... more
Late Friday, the Centers for Medicare and Medicaid Services (CMS) released the proposed 2008 Inpatient Prospective Payment System (IPPS) under which US hospitals are reimbursed under the DRG codes. As with prior years, this release is a draft statement and... more
CARLSBAD, Calif., Apr 12, 2007 (PrimeNewswire via COMTEX News Network) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that... more
Earnings Vertebron announced in a press release that 1Q:07 was its most profitable quarter ever. The Company attributes the growth to a significant sales increase over the comparable quarter last year as well as a company-wide restructuring in 3Q:06. Vertebron... more
CARLSBAD, Calif., Apr 11, 2007 (PrimeNewswire via COMTEX News Network) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that... more
New research out of the University of Pittsburgh Medical Center show that female stem cells have an edge over male stem cells in regenerating muscle. Johnny Huard et al suggest in the Journal of Cell Biology that this research is... more
Plans for more rigorous post-marketing policy are underway at the FDA with a new website that tracks post-approval device studies. The website names the manufacturer, device, study description and study status. There is no specific info on clinical studies because... more
Earnings aap Implantate AG announced 2006 revenues of EUR 18.5 million, up 38% from the previous year. The aap Group attributed the growth to the Biomaterials segment, where sales increased by 64% to EUR 12.2 million. Biomaterials now generates two... more
With a small market and conditions that are relatively rare, pediatrics hasn't drawn a lot of product development in the device space. As a result, children may receive devices that aren't appropriately sized for them or are lacking in data... more
Preliminary findings from an investigation into Biomet's options backdating announced last week showed a $50 million discrepancy between 1996 and 2006, and CFO Gregory D. Hartman and Exective Vice President of Administration Daniel P. Hann have both resigned. What does... more
The Lehman Brothers medical device research team had a fruitful visit to the beltway last week notably with Steve Phurrough, Director of the Coverage and Analysis Group at CMS and Herb Khun, CMS's Deputy Administrator. One of Lehman's findings related... more
Complete Archive
|
